Supplement launch readiness guide
A practical guide to planning a private-label supplement launch. Covers the order timeline from concept to shelf, the review-step sequence, decision points that are easy to miss and how to build a realistic launch window into your planning.
What this guide covers
- Project timeline overview — concept to shelf in six gates
- Review-step dependencies — which decisions must precede others
- Typical lead times by option: private-label catalogue, Formula Adaptation
- Artwork and label approval cycle — how long it takes and where delays originate
- Regulatory review timing relative to the production run
- Internal team requirements — who in your organisation needs to be involved at each review step
- Common launch delays and how to prevent them
Who this is for
- Brand teams with a launch window target who need to map the steps to get there
- Operators whose previous launch had delays and want to understand the bottlenecks
- Category managers building supplier timelines for a retailer or e-commerce deadline
- Founders planning a first private-label launch and building a project plan from scratch
Want to discuss your launch timeline?
Drop your work email and a DAT team member will follow up with a project roadmap based on where you are in planning.
Key points in the guide
Typical lead times by option
Where delays typically originate
- Artwork revision cycles — most common delay. Plan 3 rounds of artwork proofing, minimum.
- Claims wording review — EFSA (EU) or FDA (US) framework review adds time when the brief is incomplete.
- Novel Food or GRAS confirmation — can add 3–6 months if triggered late in the cycle.
Internal team requirements
At minimum, a private-label launch requires: a brand or product lead (owns the brief), a regulatory or compliance contact (reviews claims and labelling), and an artwork owner (approves label proofs). The guide details which decisions each gate requires and flags the gates where external reviewers (regulatory consultants, retail buyers) need to be scheduled.
How this connects to your order
After reviewing this guide, the next step is to assess where you are in the review-step sequence. If you are at concept, the guide helps you identify what needs to be resolved before you brief DAT. If you have already started conversations with a manufacturer, use the checklist to audit where your current order is and what is still blocking the specification.
DAT issues an order roadmap at the brief stage, mapping your specific timeline against the gates that apply to your route and target markets.
Download the supplement launch readiness guide (PDF)
The gate sequence, lead times by route, common delay patterns and the internal-team map — printable for project kickoff.
Related formats
The standard production lead time is the same for every format and pack — bottle, doypack or sachet.
Related markets
Per-market documentation route affects the regulatory gate timing. Pick the target market for the country-level documentation summary.
Ingredient, dosage or active changes to an existing formula are Formula Adaptation, with the production minimum and timeline confirmed before you commit. A genuinely new formula, R&D, due diligence, compliance and bespoke testing are Custom Projects, reviewed individually.
Related guides
Where to next?
Browse the reviewed catalogue, request samples, or start an order when you're ready — your DAT Supply account routes your brief through the right review step.